Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

A case of prolonged sinus arrest for 5 minutes after Cryo-balloon ablation to the left superior pulmonary vein.

Miki T, Shiraishi H, Shirayama T, Matoba S.

J Arrhythm. 2019 Nov 21;36(1):186-188. doi: 10.1002/joa3.12268. eCollection 2020 Feb.

2.

Appropriate selection of echocardiographic guidance for transcatheter atrial septal defect closure.

Yamano M, Yamano T, Nakamura T, Zen K, Shiraishi H, Shirayama T, Matoba S.

Int J Cardiovasc Imaging. 2020 Feb 10. doi: 10.1007/s10554-020-01778-9. [Epub ahead of print]

PMID:
32040685
3.

Importance of Preoperative Computed Tomography Assessment of the Membranous Septal Anatomy in Patients Undergoing Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve.

Miki T, Senoo K, Ohkura T, Kadoya Y, Ito N, Kuwabara K, Nakanishi N, Zen K, Nakamura T, Yamano T, Shiraishi H, Shirayama T, Matoba S.

Circ J. 2020 Jan 24;84(2):269-276. doi: 10.1253/circj.CJ-19-0823. Epub 2019 Dec 27.

4.

Clinical significance of rectus femoris diameter in heart failure patients.

Sato Y, Shiraishi H, Nakanishi N, Zen K, Nakamura T, Yamano T, Shirayama T, Matoba S.

Heart Vessels. 2020 May;35(5):672-680. doi: 10.1007/s00380-019-01534-7. Epub 2019 Nov 7.

PMID:
31701229
5.

In-stent Massive Thrombi Formation During Primary Percutaneous Coronary Intervention in a Patient with Acute Myocardial Infarction Complicated with Essential Thrombocythemia.

Shoji K, Yanishi K, Shiraishi J, Nakanishi N, Zen K, Nakamura T, Hyogo M, Shirayama T, Matoba S, Sawada T.

Intern Med. 2019 May 1;58(9):1287-1293. doi: 10.2169/internalmedicine.2083-18. Epub 2019 Jan 10.

6.

Brachial-Ankle Pulse Waves Reflect the Hemodynamics of Valvular Heart Disease.

Kurimoto R, Shiraishi H, Taniguchi T, Otakara A, Nakanishi N, Zen K, Nakamura T, Yamano T, Shirayama T, Yaku H, Matoba S.

J Heart Valve Dis. 2018 Jan;27(1):71-77.

PMID:
30560602
7.

Angioscopic Evaluation During Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Hypertension.

Nakanishi N, Fukai K, Tsubata H, Ogata T, Zen K, Nakamura T, Yamano T, Shiraishi H, Shirayama T, Matoba S.

Heart Lung Circ. 2019 Apr;28(4):655-659. doi: 10.1016/j.hlc.2018.08.008. Epub 2018 Sep 8.

PMID:
30224170
8.

Impact of Door-to-Balloon Time in Patients With ST-Elevation Myocardial Infarction Who Arrived by Self-Transport - Acute Myocardial Infarction-Kyoto Multi-Center Risk Study Group.

Kodama N, Nakamura T, Yanishi K, Nakanishi N, Zen K, Yamano T, Shiraishi H, Shirayama T, Shiraishi J, Sawada T, Kohno Y, Kitamura M, Furukawa K, Matoba S.

Circ J. 2017 Oct 25;81(11):1693-1698. doi: 10.1253/circj.CJ-17-0083. Epub 2017 Jun 20.

9.

Late-onset Mitochondrial Cardiomyopathy Triggered by Anticancer Treatment.

Yamasaki T, Yanishi K, Tateishi S, Nakanishi N, Zen K, Nakamura T, Yamano T, Shiraishi H, Shirayama T, Matoba S.

Intern Med. 2017;56(11):1357-1361. doi: 10.2169/internalmedicine.56.8076. Epub 2017 Jun 1.

10.

Impact of Left Ventricular Diastolic Property on Left Atrial Function from Simultaneous Left Atrial and Ventricular Three-Dimensional Echocardiographic Volume Measurement.

Yamano M, Yamano T, Iwamura Y, Nakamura T, Shiraishi H, Shirayama T, Matoba S.

Am J Cardiol. 2017 May 15;119(10):1687-1693. doi: 10.1016/j.amjcard.2017.02.002. Epub 2017 Feb 28.

PMID:
28363352
11.

A Simple Risk Stratification Model for ST-Elevation Myocardial Infarction (STEMI) from the Combination of Blood Examination Variables: Acute Myocardial Infarction-Kyoto Multi-Center Risk Study Group.

Yanishi K, Nakamura T, Nakanishi N, Yokota I, Zen K, Yamano T, Shiraishi H, Shirayama T, Shiraishi J, Sawada T, Kohno Y, Kitamura M, Furukawa K, Matoba S.

PLoS One. 2016 Nov 11;11(11):e0166391. doi: 10.1371/journal.pone.0166391. eCollection 2016.

12.

Relationship Between Mean Blood Pressure at Admission and In-Hospital Outcome After Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction.

Shiraishi J, Nakamura T, Shikuma A, Shoji K, Nishikawa M, Yanagiuchi T, Ito D, Kimura M, Kishita E, Nakagawa Y, Hyogo M, Sawada T, Yamada H, Matsumuro A, Shirayama T, Kitamura M, Kohno Y, Furukawa K, Matoba S; AMI-Kyoto Multi-Center Risk Study Group.

Int Heart J. 2016 Sep 28;57(5):547-52. doi: 10.1536/ihj.15-480. Epub 2016 Aug 16.

13.

Effects of electrical stimulation therapy on the blood flow in chronic critical limb ischemia patients following regenerative therapy.

Yamabata S, Shiraishi H, Munechika M, Fukushima H, Fukuoka Y, Hojo T, Shirayama T, Horii M, Matoba S, Kubo T.

SAGE Open Med. 2016 Jul 22;4:2050312116660723. doi: 10.1177/2050312116660723. eCollection 2016.

14.

Usefulness of peripheral arterial signs in the evaluation of aortic regurgitation.

Shiraishi H, Shirayama T, Maruyama N, Kaimoto S, Otakara A, Kurimoto R, Nakanishi N, Nakamura T, Yamano T, Matsumuro A, Doi K, Yaku H, Matoba S.

J Cardiol. 2017 May;69(5):769-773. doi: 10.1016/j.jjcc.2016.07.005. Epub 2016 Aug 5.

15.

Efficacy of Antiarrhythmic Drugs Short-Term Use After Catheter Ablation for Atrial Fibrillation (EAST-AF) trial.

Kaitani K, Inoue K, Kobori A, Nakazawa Y, Ozawa T, Kurotobi T, Morishima I, Miura F, Watanabe T, Masuda M, Naito M, Fujimoto H, Nishida T, Furukawa Y, Shirayama T, Tanaka M, Okajima K, Yao T, Egami Y, Satomi K, Noda T, Miyamoto K, Haruna T, Kawaji T, Yoshizawa T, Toyota T, Yahata M, Nakai K, Sugiyama H, Higashi Y, Ito M, Horie M, Kusano KF, Shimizu W, Kamakura S, Morimoto T, Kimura T, Shizuta S; EAST-AF Trial Investigators.

Eur Heart J. 2016 Feb 14;37(7):610-8. doi: 10.1093/eurheartj/ehv501. Epub 2015 Sep 28.

PMID:
26417061
16.

Survivors of acute myocardial infarction at left main trunk undergoing primary percutaneous coronary intervention.

Hashimoto S, Shiraishi J, Nakamura T, Nishikawa M, Yanagiuchi T, Ito D, Kimura M, Kishita E, Nakagawa Y, Hyogo M, Shima T, Sawada T, Matoba S, Yamada H, Matsumuro A, Shirayama T, Kitamura M, Kohno Y, Furukawa K.

Cardiovasc Interv Ther. 2016 Apr;31(2):89-95. doi: 10.1007/s12928-015-0352-2. Epub 2015 Sep 5.

PMID:
26342479
17.

Adenosine triphosphate-guided pulmonary vein isolation for atrial fibrillation: the UNmasking Dormant Electrical Reconduction by Adenosine TriPhosphate (UNDER-ATP) trial.

Kobori A, Shizuta S, Inoue K, Kaitani K, Morimoto T, Nakazawa Y, Ozawa T, Kurotobi T, Morishima I, Miura F, Watanabe T, Masuda M, Naito M, Fujimoto H, Nishida T, Furukawa Y, Shirayama T, Tanaka M, Okajima K, Yao T, Egami Y, Satomi K, Noda T, Miyamoto K, Haruna T, Kawaji T, Yoshizawa T, Toyota T, Yahata M, Nakai K, Sugiyama H, Higashi Y, Ito M, Horie M, Kusano KF, Shimizu W, Kamakura S, Kimura T; UNDER-ATP Trial Investigators.

Eur Heart J. 2015 Dec 7;36(46):3276-87. doi: 10.1093/eurheartj/ehv457. Epub 2015 Aug 30.

PMID:
26321237
18.

Case of fibromuscular dysplasia with multiple aneurysms in a young woman.

Yanishi K, Kasahara A, Nakamura T, Yamano T, Shiraishi H, Matsumuro A, Shirayama T, Kawahito Y, Matoba S.

J Cardiol Cases. 2015 Jun 12;12(3):79-82. doi: 10.1016/j.jccase.2015.05.005. eCollection 2015 Sep.

19.

A protective role of Nox1/NADPH oxidase in a mouse model with hypoxia-induced bradycardia.

Kojima A, Matsumoto A, Nishida H, Reien Y, Iwata K, Shirayama T, Yabe-Nishimura C, Nakaya H.

J Pharmacol Sci. 2015 Mar;127(3):370-6. doi: 10.1016/j.jphs.2015.02.007. Epub 2015 Feb 17.

20.

Two cases of delayed cardiac tamponade due to pericarditis after pulmonary vein (PV) isolation for atrial fibrillation.

Torihashi S, Shiraishi H, Hamaoka T, Imai M, Kuroyanagi A, Nakanishi N, Nakamura T, Yamano T, Matsumuro A, Shirayama T.

Intern Med. 2015;54(7):791-6. doi: 10.2169/internalmedicine.54.2537. Epub 2015 Apr 1.

21.

Angioscopic observation in chronic thromboembolic pulmonary hypertension before and after balloon pulmonary angioplasty.

Nakanishi N, Nakamura T, Yamano T, Shiraishi H, Matoba S, Matsumuro A, Shirayama T.

J Cardiovasc Med (Hagerstown). 2016 Dec;17 Suppl 2:e129-e131. doi: 10.2459/JCM.0000000000000166.

PMID:
25083723
22.

Clinical impact of thrombus aspiration during primary percutaneous coronary intervention in acute myocardial infarction with occluded culprit.

Shiraishi J, Kohno Y, Nakamura T, Yanagiuchi T, Hashimoto S, Ito D, Kimura M, Matsui A, Yokoi H, Arihara M, Hyogo M, Shima T, Sawada T, Matoba S, Yamada H, Matsumuro A, Shirayama T, Kitamura M, Furukawa K.

Cardiovasc Interv Ther. 2015 Jan;30(1):22-8. doi: 10.1007/s12928-014-0282-4. Epub 2014 Jul 2.

PMID:
24986060
23.

Prognostic impact of chronic kidney disease and anemia at admission on in-hospital outcomes after primary percutaneous coronary intervention for acute myocardial infarction.

Shiraishi J, Kohno Y, Nakamura T, Yanagiuchi T, Hashimoto S, Ito D, Kimura M, Matsui A, Yokoi H, Arihara M, Hyogo M, Shima T, Sawada T, Matoba S, Yamada H, Matsumuro A, Shirayama T, Kitamura M, Furukawa K; AMI-Kyoto Multi-Center Risk Study Group.

Int Heart J. 2014;55(4):301-6. Epub 2014 Jun 2.

24.

Predictors of in-hospital outcomes after primary percutaneous coronary intervention for acute myocardial infarction in patients with a high Killip class.

Shiraishi J, Kohno Y, Nakamura T, Yanagiuchi T, Hashimoto S, Ito D, Kimura M, Matsui A, Yokoi H, Arihara M, Hyogo M, Shima T, Sawada T, Matoba S, Yamada H, Matsumuro A, Shirayama T, Kitamura M, Furukawa K; AMI-Kyoto Multi-Center Risk Study Group.

Intern Med. 2014;53(9):933-9. Epub 2014 May 1.

25.

Nonsense-mediated mRNA decay due to a CACNA1C splicing mutation in a patient with Brugada syndrome.

Fukuyama M, Ohno S, Wang Q, Shirayama T, Itoh H, Horie M.

Heart Rhythm. 2014 Apr;11(4):629-34. doi: 10.1016/j.hrthm.2013.12.011. Epub 2013 Dec 7.

PMID:
24321233
26.

Prognostic impact of pulse pressure at admission on in-hospital outcome after primary percutaneous coronary intervention for acute myocardial infarction.

Shiraishi J, Kohno Y, Sawada T, Hashimoto S, Ito D, Kimura M, Matsui A, Yokoi H, Arihara M, Irie H, Hyogo M, Shima T, Nakamura T, Matoba S, Yamada H, Matsumuro A, Shirayama T, Kitamura M, Furukawa K, Matsubara H.

Heart Vessels. 2013 Jul;28(4):434-41. doi: 10.1007/s00380-012-0277-y. Epub 2012 Aug 28.

PMID:
22926409
27.

Prognostic impact of systolic blood pressure at admission on in-hospital outcome after primary percutaneous coronary intervention for acute myocardial infarction.

Shiraishi J, Kohno Y, Sawada T, Hashimoto S, Ito D, Kimura M, Matsui A, Yokoi H, Arihara M, Irie H, Hyogo M, Shima T, Nakamura T, Matoba S, Yamada H, Matsumuro A, Shirayama T, Kitamura M, Furukawa K, Matsubara H.

J Cardiol. 2012 Aug;60(2):139-44. doi: 10.1016/j.jjcc.2012.02.008. Epub 2012 Apr 21.

28.

Systolic blood pressure at admission, clinical manifestations, and in-hospital outcomes in patients with acute myocardial infarction.

Shiraishi J, Kohno Y, Sawada T, Ito D, Kimura M, Ariyoshi M, Matsui A, Arihara M, Irie H, Hyogo M, Shima T, Nakamura T, Matoba S, Yamada H, Matsumuro A, Shirayama T, Kitamura M, Furukawa K, Matsubara H.

J Cardiol. 2011 Jul;58(1):54-60. doi: 10.1016/j.jjcc.2011.04.003. Epub 2011 May 31.

29.

Klotho is associated with VEGF receptor-2 and the transient receptor potential canonical-1 Ca2+ channel to maintain endothelial integrity.

Kusaba T, Okigaki M, Matui A, Murakami M, Ishikawa K, Kimura T, Sonomura K, Adachi Y, Shibuya M, Shirayama T, Tanda S, Hatta T, Sasaki S, Mori Y, Matsubara H.

Proc Natl Acad Sci U S A. 2010 Nov 9;107(45):19308-13. doi: 10.1073/pnas.1008544107. Epub 2010 Oct 21.

30.

Clinical manifestations and effects of primary percutaneous coronary intervention for patients with delayed pre-hospital time in acute myocardial infarction.

Nomura T, Tatsumi T, Sawada T, Kojima A, Urakabe Y, Enomoto-Uemura S, Nishikawa S, Keira N, Nakamura T, Matoba S, Yamada H, Matsumuro A, Shirayama T, Shiraishi J, Kohno Y, Kitamura M, Furukawa K, Matsubara H; AMI-Kyoto Multi-Center Risk Study Group.

J Cardiol. 2010 Sep;56(2):204-10. doi: 10.1016/j.jjcc.2010.05.004. Epub 2010 Jun 22.

31.

Predictors of nonoptimal coronary flow after primary percutaneous coronary intervention with stent implantation for acute myocardial infarction.

Shiraishi J, Kohno Y, Sawada T, Takeda M, Arihara M, Hyogo M, Shima T, Okada T, Nakamura T, Matoba S, Yamada H, Matsumuro A, Shirayama T, Kitamura M, Furukawa K, Matsubara H; AMI-Kyoto Multi-Center Risk Study Group.

J Cardiol. 2010 Mar;55(2):217-23. doi: 10.1016/j.jjcc.2009.11.001. Epub 2009 Dec 16.

32.

Influence of previous myocardial infarction site on in-hospital outcome after primary percutaneous coronary intervention for repeat myocardial infarction.

Shiraishi J, Kohno Y, Sawada T, Takeda M, Arihara M, Hyogo M, Shima T, Okada T, Nakamura T, Matoba S, Yamada H, Matsumuro A, Shirayama T, Kitamura M, Furukawa K, Matsubara H.

J Cardiol. 2010 Jan;55(1):77-83. doi: 10.1016/j.jjcc.2009.09.001. Epub 2009 Nov 5.

33.

Spontaneous pericardial hematoma with familial amyloid polyneuropathy.

Nakanishi N, Sawada T, Sato R, Yanishi K, Akakabe Y, Nishizawa S, Kuroyanagi A, Tsubakimoto Y, Matsui A, Nakamura T, Shiraishi H, Matsumuro A, Shirayama T, Matsubara H.

Amyloid. 2009 Dec;16(4):221-5. doi: 10.3109/13506120903421751.

PMID:
19922334
34.

Long-term follow-up of "reversible" dilated cardiomyopathy with improvement of cardiac sympathetic nerve activity after cardiac resynchronization therapy (CRT): Do "CRT superresponders" have "dyssynchrony-induced cardiomyopathy"?

Ishibashi K, Osamura T, Shiraishi H, Shirayama T, Yamahara Y, Matsubara H.

J Cardiol Cases. 2009 Nov 8;1(1):e56-e62. doi: 10.1016/j.jccase.2009.07.004. eCollection 2010 Feb.

35.

Altered expression of Na+ transporters at the mRNA level in rat normal and hypertrophic myocardium.

Yamamoto T, Shirayama T, Takahashi T, Matsubara H.

Heart Vessels. 2009 Jan;24(1):54-62. doi: 10.1007/s00380-008-1071-8. Epub 2009 Jan 23.

PMID:
19165570
36.

Losartan decreased premature ventricular contractions in patients with hypertension.

Shiraishi H, Shirayama T, Sakamoto T, Kuroyanagi A, Matsubara H.

J Hum Hypertens. 2009 Apr;23(4):289-91. doi: 10.1038/jhh.2008.122. Epub 2008 Oct 9.

PMID:
18843280
37.

Predictors of in-hospital outcome after primary percutaneous coronary intervention for recurrent myocardial infarction.

Shiraishi J, Kohno Y, Sawada T, Takeda M, Arihara M, Hyogo M, Yagi T, Shima T, Okada T, Nakamura T, Matoba S, Yamada H, Shirayama T, Kitamura M, Furukawa K, Matsubara H; AMI-Kyoto Multi-Center Risk Study Group.

Circ J. 2008 Aug;72(8):1225-9.

38.

Effects of hospital volume of primary percutaneous coronary interventions on angiographic results and in-hospital outcomes for acute myocardial infarction.

Shiraishi J, Kohno Y, Sawada T, Arihara M, Hyogo M, Yagi T, Shima T, Okada T, Nakamura T, Matoba S, Yamada H, Shirayama T, Tatsumi T, Kitamura M, Furukawa K, Matsubara H; AMI-Kyoto Multi-Center Risk Study Group.

Circ J. 2008 Jul;72(7):1041-6.

39.

Enhanced activity of ventricular Na+-HCO3- cotransport in pressure overload hypertrophy.

Yamamoto T, Shirayama T, Sakatani T, Takahashi T, Tanaka H, Takamatsu T, Spitzer KW, Matsubara H.

Am J Physiol Heart Circ Physiol. 2007 Aug;293(2):H1254-64. Epub 2007 Apr 6.

40.

Role of atrial fibrillation threshold evaluation on guiding treatment.

Shirayama T.

Indian Pacing Electrophysiol J. 2003 Oct 1;3(4):224-30.

41.

Cardiac hypertrophy diminished the effects of isoproterenol on delayed rectifier potassium current in rat heart.

Sakatani T, Shirayama T, Yamamoto T, Mani H, Shiraishi H, Matsubara H.

J Physiol Sci. 2006 Apr;56(2):173-81. Epub 2006 Mar 29.

PMID:
16839443
42.

Usefulness of paroxetine in depressed men with paroxysmal atrial fibrillation.

Shirayama T, Sakamoto T, Sakatani T, Mani H, Yamamoto T, Matsubara H.

Am J Cardiol. 2006 Jun 15;97(12):1749-51. Epub 2006 Apr 21.

PMID:
16765127
43.

Efficacy of biventricular pacing for dialysis-related hypotension due to idiopathic dilated cardiomyopathy.

Kusaba T, Tanda S, Kameyama H, Tamagaki K, Okigaki M, Hatta T, Suzaki Y, Shirayama T, Matsubara H, Sasaki S.

Clin Exp Nephrol. 2005 Sep;9(3):255-9.

PMID:
16189637
44.

The association between cholesterol and mortality in heart failure. Comparison between patients with and without coronary artery disease.

Sakatani T, Shirayama T, Suzaki Y, Yamamoto T, Mani H, Kawasaki T, Sugihara H, Matsubara H.

Int Heart J. 2005 Jul;46(4):619-29.

45.

Clinical significance of preserving spontaneous QRS wave in the therapy of DDD pacing for sick sinus syndrome.

Mani H, Shirayama T, Suzaki Y, Sakatani T, Sakamoto T, Yamamura M, Matsubara H, Taniwaki M.

Pacing Clin Electrophysiol. 2004 Sep;27(9):1212-6.

PMID:
15461710
46.

Rate-dependent QRS prolongation during exercise testing associated with hyperkalemia.

Shiraishi H, Hyogo M, Ishibashi K, Urao N, Tsukamoto M, Keira N, Hirasaki S, Shirayama T, Nakagawa M, Matsubara H.

J Electrocardiol. 2004 Jul;37(3):241-5.

PMID:
15286939
47.

Aldosterone directly induces myocyte apoptosis through calcineurin-dependent pathways.

Mano A, Tatsumi T, Shiraishi J, Keira N, Nomura T, Takeda M, Nishikawa S, Yamanaka S, Matoba S, Kobara M, Tanaka H, Shirayama T, Takamatsu T, Nozawa Y, Matsubara H.

Circulation. 2004 Jul 20;110(3):317-23. Epub 2004 Jul 12. Retraction in: Circulation. 2013 Jun 11;127(23):e842.

PMID:
15249508
48.

Ebstein anomaly associated with unusual conduction delay and sick sinus syndrome.

Mani H, Shirayama T, Yamamura M, Sakamoto T, Yoshida A, Nakagawa M.

Circ J. 2004 Jul;68(7):719-21.

49.

Idiopathic long QT syndrome with early afterdepolarization induced by epinephrine. Acase report.

Urao N, Shiraishi H, Ishibashi K, Hyogo M, Tsukamoto M, Keira N, Hirasaki S, Shirayama T, Nakagawa M.

Circ J. 2004 Jun;68(6):587-91.

50.

Subepicardial aneurysm associated with ventricular septal perforation showing a normal coronary angiogram.

Shiraishi H, Urao N, Tsukamoto M, Hyogo M, Keira N, Hirasaki S, Ishibashi K, Shirayama T, Nakagawa M.

Circ J. 2003 Nov;67(11):962-4.

Supplemental Content

Loading ...
Support Center